RxDoctor Payments Data

Hazem Sokkar, MD

Psychiatry · Tulsa, OKNPI 1780659078

Payments from drug & device makers

$1,365in general payments, 2019–2025

Across 60 payments — averaging $22.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axsome Therapeutics, Inc.$221
  • Eisai Inc.$195
  • AbbVie$176
  • Johnson & Johnson$156
  • Takeda Pharmaceuticals U.S.A., Inc.$134
  • Otsuka America Pharmaceutical, Inc.$104
  • plus $379 from 11 others

What the payments were for

  • Food & beverage$1,365100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,365 in reported general payments places this provider in the 75th percentile of 328 psychiatry providers in Oklahoma.

See all psychiatry providers in Oklahoma

Medicare billing

Part B allowed, 2024
$35,485
Medicare patients
15
Services billed
342

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole21$4,601
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine40$2,107
Alprazolam227$1,151
Lurasidone Hcl13$642
Zolpidem Tartrate92$578
Duloxetine Hcl37$537
Doxepin Hcl14$419
Lamotrigine55$306
Mirtazapine28$301
Clonazepam29$275
Paroxetine Hcl11$272
Trazodone Hcl37$243
Escitalopram Oxalate36$218
Bupropion XlBupropion Hcl11$181
Diazepam13$168

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Almatica Pharma LLCSertraline Hcl$69$8626 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 328 psychiatry providers in Oklahoma.

Other psychiatry in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →